NEW YORK (GenomeWeb) – Australian molecular diagnostics firm Genetic Technologies announced today that it has regained compliance with the Nasdaq's $1 minimum bid price requirement.
NEW YORK (GenomeWeb) – Australian molecular diagnostics firm Genetic Technologies announced today that it has regained compliance with the Nasdaq's $1 minimum bid price requirement.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.